BD (NYSE:BDX) announced today that it will begin remediation for a 2020 recall of its Alaris infusion system.
Franklin Lakes, N.J.-based BD’s remediation for the Feb. 4, 2020, recall of the BD Alaris system will begin through a new version of software after a voluntary recall alerted customers to a number of areas in which the pump may not operate as expected. Those areas included software errors related to System Error Code 255-XX-XXX, delay options programming, low battery alarm failure, keep vein open/End of Infusion alarms priority and user errors related to Customer Concentrations Programming.
Get the full story at our sister site, Drug Delivery Business News.